Thus, we investigated the NGF‐mediated control of APP phosphorylation/processing in the forebrain and the underlying molecular mechanisms using in vitro (primary septal neurons), ex vivo (septo‐hippocampal [SH] slices), and in vivo (KO mice and AD brain tissues) experimental paradigms. This evidence concerns the gene NGF and Alzheimer disease.